Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management

By afschroeder • April 30, 2026

Fracol ME, Miranda RN, Tsao AS, Rodriguez MM, Nastoupil LJ, Young PA, Sherrod AE, LeBlanc DM, Hunsicker LM, Bacchi CE, Gabriel T, Myckatyn TM, Tanaka S, Kuykendall LV, Resetkova E, Evans MG, Jagasia P, McCarthy CM, Santanelli Di Pompeo F, Hunt KK, Medeiros LJ, Haymaker C, Clemens MW. Breast Implant-Associated Malignancies: Current Recommendations for Workup and Management. Plast Reconstr Surg. 2026 May 1;157(5):774e-784e. doi: 10.1097/PRS.0000000000012796. Epub 2026 Apr 29. PMID: 42054062.

Tags: Hematology/Oncology, Publications

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement

Llovet JM, Mauro E, Rimassa L, Mazzaferro V, Pinter M, Kelley RK, Chan SL, Kulik L, Pillai A, Roberts L, Sangro B, Casanovas T, Kaplan[...]

Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome type 1

Lim A, Peluso EM, Downs IA, Horwich BH, Velez-Velez MA, Lechner MG. Severe autoimmunity after checkpoint inhibitor therapy in a patient with autoimmune polyglandular syndrome[...]

A phase 1 trial of HPV16 E7 T-cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers (KITE-439 trial)

Kirtane K, Niu J, Blumenschein G, Massarelli E, Hanna GJ, Lee S, Bishop MR, Konecny GE, Mao D, Zheng Y, Rodriguez K, Kim JJ, Williams[...]